Rifxima tablets 200 mg for hepatic encephalopathy (hyperammonemia, rifaximin, Xifaxan, Xifaxanta, Normix)
What are Rifxima tablets 200 mg for hepatic encephalopathy. (hyperammonemia. Xifaxan. Xifaxanta. Normix)?
Rifxima tablets are formulated with the potent semisynthetic broad-spectrum antibacterial agent, rifaximin. This medication exerts its therapeutic effects by addressing the root cause of hepatic encephalopathy - the gut microbiota that produce ammonia.
Hepatic encephalopathy, a serious neurological complication arising from liver dysfunction, is characterized by the accumulation of toxic ammonia in the bloodstream due to impaired liver function. This accumulation leads to cognitive impairment, confusion, and even coma in severe cases. Rifxima tablets' mechanism intervenes in the gastrointestinal tract, selectively targeting and eliminating ammonia-producing gut bacteria.
By curbing the production of ammonia in the gut, Rifxima tablets help to reduce the severity and frequency of hepatic encephalopathy episodes. This, in turn, leads to a decrease in mortality rates among patients suffering from this debilitating condition. Moreover, by ameliorating the hyperammonemia symptoms, Rifxima tablets significantly improve the quality of life for patients afflicted with hepatic encephalopathy. Rifxima tablets can also be prescribed as an orphan drug.
Research and clinical studies have demonstrated that Rifxima exhibits an impressive preventive effect, reducing the likelihood of recurrent episodes of hepatic encephalopathy in patients. This finding opens up new avenues for long-term management strategies and offers hope to those at risk of recurrent bouts of this distressing condition.
Active principles: rifaximin
Amount: 100 tablets
Maker: ASKA Pharmaceutical Co. Ltd., Tokyo, Japan
Indications: treatment of hyperammonemia due to hepatic enzymephalopathy
How to take
Adults should take 2 tablets (400 mg of active principle) 3 times a day, after meals.
Contraindications: do not use for the following patients:
- pregnant women,
- breastfeeding women,
- patients with liver disease,
- patients with tuberculosis.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.